A sandwich enzyme immunoassay was developed to detect circulating immune complexes containing carcinoembryonic antigen (CEA) and immunoglobulin (Ig) G, IgA, or IgM using a nitrocellulose-bound anti-CEA antibody as the solid phase reagent. Elevated levels of CEA-containing circulating immune complexe
Immunoglobulin complexes in sera of patients with malignancy
โ Scribed by Edwardo A. Samayoa; Frederic C. McDuffie; Audrey M. Nelson; Vay L. W. Go; Harvinder S. Luthra; Hilton W. Brumfield
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- French
- Weight
- 556 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Sera frour 146 patients with malignancy, 59 normal controls and 42 patients hospitalized with nonโmalignant diseases were examined by a precipitin test with monoclonal rheumatoid factor (mRF) for the presence of circulating immune complexes containing IgG. Fortyโtwo (29%) of the sera from cancer patients but only two of the sera from patients in each of the control groups contained such material. Similar results were obtained with a radioimmunoโassay for immune complexes based on the same mRF. Sera from 23 of 65 patients with metastatic malignancy (35%) had elevated levels of immune complexes by this latter test. The presence of the material was not related to the source of malignancy, presence of carcinoembryonic or hepatitis antigens or of such autoantibodies as rheumatoid factor or antiโDNA. By density gradient ultracentrifugation the reacting material was identified as being of molecular size 19s or greater. It has not yet been further characterized with regard to the nature of any antigens present.
๐ SIMILAR VOLUMES
Zentrum der Dermatologie und Venerologie (Biochemie) der J. W. Goethe-Universit~it, Theodor-Stern-Kai 7, D-6000 Frankfurt a. M., Federal Republic of Germany Summary. Sera of patients with various malignancies are known to contain DNA-binding proteins (DBP) which are not present in sera of normal ind
## Abstract Serum tyrosinase activity has been measured by adapting the [^3^]tyrosine assay for tyrosinase and significant elevations of serum tyrosinase activity were found in patients with malignant melanoma. In contrast to findings in a study which utilized [^14^C]tyrosine, augmented levels of t